Table 2.
Adipo/cytokine levels in secretome samples
| Unstable carotid atherosclerotic plaque group | Coronary patients with non-atherosclerotic mammary artery | |
|---|---|---|
| (n = 18) | (n = 13) | |
| Mean ± SD | Mean ± SD | |
| Visfatin (ng/μg total protein) | 0.100 ± 0.017 | 0.046 ± 0.012a |
| Adiponectin (μg/μg total protein) | 0.311 ± 0.039 | 0.369 ± 0.096 |
| IL-6 (pg/μg total protein) | 0.048 ± 0.012 | 0.039 ± 0.008 |
| Lipocalin-2 (ng/μg total protein) | 0.009 ± 0.002 | 0.008 ± 0.001 |
| Resistin (ng/μg total protein) | 0.001 ± 0.001 | 0.001 ± 0.001 |
| TNFR2 (ng/μg total protein) | 0.007 ± 0.002 | 0.005 ± 0.001 |
IL-6 interleukin 6, TNFR2 tumor necrosis factor receptor 2. Data are expressed as mean ± SD. p <0.05 are considered statistically significant. arefer to the statistically significant differences between unstable carotid atherosclerotic plaque and non-atherosclerotic mammary artery group